Intervention Review

Taxanes for adjuvant treatment of early breast cancer

  1. Thomas Ferguson2,
  2. Nicholas Wilcken3,
  3. Rosemary Vagg4,
  4. Davina Ghersi5,
  5. Anna K Nowak1,*

Editorial Group: Cochrane Breast Cancer Group

Published Online: 17 OCT 2007

Assessed as up-to-date: 8 JAN 2007

DOI: 10.1002/14651858.CD004421.pub2


How to Cite

Ferguson T, Wilcken N, Vagg R, Ghersi D, Nowak AK. Taxanes for adjuvant treatment of early breast cancer. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD004421. DOI: 10.1002/14651858.CD004421.pub2.

Author Information

  1. 1

    Sir Charles Gardiner Hospital and University of Western Australia, Department of Medical Oncology, Perth, WA, Australia

  2. 2

    Sir Charles Gairdner Hospital, Department of Medical Oncology, Nedlands, WA, Australia

  3. 3

    Westmead and Nepean Hospitals, Medical Oncology, Westmead, NSW, Australia

  4. 4

    National Breast Cancer Centre, Research, Camperdown, NSW, Australia

  5. 5

    NHMRC Clinical Trials Centre, The University of Sydney, Systematic Reviews and Healthcare Assessment, Camperdown, NSW, Australia

*Anna K Nowak, Department of Medical Oncology, Sir Charles Gardiner Hospital and University of Western Australia, B Block, Hospital Avenue, Nedlands, Perth, WA, 6099, Australia. anowak@cyllene.uwa.edu.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mova Leung, Joy Florendo, Jessica Kano, Tiffany Marr-Del Monte, Brian Higgins, Robert Myers, Trishala Menon, Glenn Jones, A modified filgrastim regimen does not reduce pain burden compared to pegfilgrastim in women receiving chemotherapy for non-metastatic breast cancer, Supportive Care in Cancer, 2014,

    CrossRef

  2. 2
    Rachel Webber-Foster, Giorgi Kvizhinadze, Gareth Rivalland, Tony Blakely, Cost-Effectiveness Analysis of Docetaxel Versus Weekly Paclitaxel in Adjuvant Treatment of Regional Breast Cancer in New Zealand, PharmacoEconomics, 2014, 32, 7, 707

    CrossRef

  3. 3
    C. Andersen, M. Rørth, B. Ejlertsen, L. Adamsen, Exercise despite pain – breast cancer patient experiences of muscle and joint pain during adjuvant chemotherapy and concurrent participation in an exercise intervention, European Journal of Cancer Care, 2014, 23, 5
  4. 4
    Andrew Caley, Alpa Kanji, Jake Tanguay, Adjuvant therapy, Medicine, 2012, 40, 1, 1

    CrossRef

  5. 5
    Yin Ting Cheung, Wai Keung Chui, Alexandre Chan, Neuro-cognitive impairment in breast cancer patients: Pharmacological considerations, Critical Reviews in Oncology/Hematology, 2012, 83, 1, 99

    CrossRef

  6. 6
    H.E. Campbell, D. Epstein, D. Bloomfield, S. Griffin, A. Manca, J. Yarnold, J. Bliss, L. Johnson, H. Earl, C. Poole, L. Hiller, J. Dunn, P. Hopwood, P. Barrett-Lee, P. Ellis, D. Cameron, A.L. Harris, A.M. Gray, M.J. Sculpher, The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses, European Journal of Cancer, 2011, 47, 17, 2517

    CrossRef

  7. 7
    Richard H DE BOER, Arlene CHAN, Ben TRAN, Nicholas WILCKEN, Use of non-anthracycline regimens in early stage breast cancer in Australia, Asia-Pacific Journal of Clinical Oncology, 2011, 7, 1
  8. 8
    Catherine M. Kelly, Gabriel N. Hortobagyi, Adjuvant Chemotherapy in Early-Stage Breast Cancer: What, When, and for Whom?, Surgical Oncology Clinics of North America, 2010, 19, 3, 649

    CrossRef

  9. 9
    A. Tardivon, C. Malhaire, Cancer du sein (II). Procédures diagnostiques et thérapeutiques, EMC - Radiologie et imagerie médicale - Génito-urinaire - Gynéco-obstétricale - Mammaire, 2009, 4, 3, 1

    CrossRef

  10. 10
    Paul Ellis, Peter Barrett-Lee, Lindsay Johnson, David Cameron, Andrew Wardley, Susan O'Reilly, Mark Verrill, Ian Smith, John Yarnold, Robert Coleman, Helena Earl, Peter Canney, Chris Twelves, Christopher Poole, David Bloomfield, Penelope Hopwood, Stephen Johnston, Mitchell Dowsett, John MS Bartlett, Ian Ellis, Clare Peckitt, Emma Hall, Judith M Bliss, Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial, The Lancet, 2009, 373, 9676, 1681

    CrossRef

  11. 11
    Miguel Martin, Unravelling the mystery of the TACT trial, The Lancet, 2009, 373, 9676, 1662

    CrossRef

  12. 12
    Cancer du sein, 2009,

    CrossRef

  13. 13
    S.-C. Tang, Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials, Breast Diseases: A Year Book Quarterly, 2008, 19, 3, 275

    CrossRef

  14. 14
    Rafael Diaz-Nieto, Massimo Varcada, Marc Winslet, Post-surgical chemotherapy versus surgery alone for resectable gastric cancer, The Cochrane Library,
  15. 15
    Rafael Diaz-Nieto, Rafael Orti-Rodríguez, Marc Winslet, Post-surgical chemotherapy versus surgery alone for resectable gastric cancer, The Cochrane Library,